Novel splice variants of prostate-specific antigen and applications in diagnosis of prostate cancer

Clinical Biochemistry

Volumn 41, Issue 7-8, 2008, Pages 591-597

  Pampalakis, Georgios ^a   Scorilas, Andreas ^b   Sotiropoulou, Georgia ^a  

^a UNIVERSITY OF PATRAS   (Greece)

^b UNIVERSITY OF ATHENS   (Greece)

Author keywords

Benign prostate hyperplasia; Biomarkers; Differential diagnosis; Isoforms; Prostate cancer; Prostate specific antigen; Splice variants

Indexed keywords

CONTIG; EPITOPE; KALLIKREIN; KALLIKREIN 3; PROSTATE SPECIFIC ANTIGEN; UNCLASSIFIED DRUG;

ADULT; AGED; ANTIGEN EXPRESSION; ARTICLE; CANCER EPIDEMIOLOGY; CANCER SCREENING; CASE FINDING; CLINICAL ARTICLE; CONTROLLED STUDY; DNA SEQUENCE; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOASSAY; MALE; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; PROSTATE CANCER; PROSTATE HYPERTROPHY; PROTEIN ANALYSIS; PROTEIN EXPRESSION; PROTEIN VARIANT; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION;

AGED; AGED, 80 AND OVER; AMINO ACID SEQUENCE; CELL LINE, TUMOR; HUMANS; HYPERPLASIA; MALE; MIDDLE AGED; MOLECULAR SEQUENCE DATA; PROSTATE; PROSTATE-SPECIFIC ANTIGEN; PROSTATIC NEOPLASMS; PROTEIN ISOFORMS; TUMOR MARKERS, BIOLOGICAL;

EID: 41849121543     PISSN: 00099120     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.clinbiochem.2007.12.022     Document Type: Article

References (30)

1. Borgoño C.A., and Diamandis E.P. The emerging roles of human tissue kallikreins in cancer [Review]. Nat Rev Cancer 4 (2004) 876-890
2. Stenman U.-H., Leinonen J., Zhang P., and Finne W.M. Prostate-specific antigen [Review]. Semin Cancer Biol 9 (1999) 83-93
3. Nadler R.B., Humphrey P.A., Smith D.S., Catalona, and Ratliff T.L. Effect of inflammation and benign prostatic hyperplasia on elevated serum prostate specific antigen levels. J Urol 154 (1995) 407-413
4. Heuze N., Olayat S., Gutman N., Zani M.L., and Courty Y. Molecular cloning and expression of an alternative hKLK3 transcript coding for a variant protein of prostate-specific antigen. Cancer Res 59 (1999) 2820-2824
5. Modrek B., and Lee C. A genomic view of alternative splicing [Review]. Nat Genet 30 (2002) 13-19
6. Naya Y., Fritsche H.A., Bhadkamkar V.A., Mikolajczyk S.D., Rittenhouse H.G., and Babaian R.J. Evaluation of precursor prostate-specific antigen isoform ratios in the detection of prostate cancer. Urol Oncol 23 (2005) 16-21
7. Donohue M.J., Satterfield M.B., Dalluge J.J., Welch M.J., Girard J.E., and Bunk D.M. Capillary electrophoresis for the investigation of prostate-specific antigen heterogeneity. Anal Biochem 15 (2005) 318-327
8. Heuze-Vourc'h N., Leblond V., and Courty Y. Complex alternative splicing of the hKLK3 gene coding for the tumor marker PSA (prostate-specific-antigen). Eur J Biochem 270 (2003) 706-714
9. Tanaka T., Isono T., Yoshiki T., Yuasa T., and Okada Y. A novel form of prostate-specific antigen transcript produced by alternative splicing. Cancer Res 60 (2000) 56-59
10. David A., Mabjeesh N., Azar I., et al. Unusual alternative splicing within the human kallikrein genes KLK2 and KLK3 gives rise to novel prostate-specific proteins. J Biol Chem 77 (2002) 8084-8090
11. Schulz P., Stucka R., Feldmann H., Combriato G., Klobeck H.G., and Fittler F. Sequence of a cDNA clone encompassing the complete mature human prostate specific antigen (PSA) and an unspliced leader sequence. Nucleic Acids Res 16 (1988) 6226
12. Burset M., Seledtsov I.A., and Solovyev V.V. Analysis of canonical and non-canonical splice sites in mammalian genomes. Nucleic Acid Res 28 (2000) 4364-4375
13. Luo L., Herbrick J.A., Scherer S.W., Beatty B., Squire J., and Diamandis E.P. Structural characterization and mapping of the normal epithelial cell-specific 1 gene. Biochem Biophys Res Commun 247 (1998) 580-586
14. Stenman U.-H., Paus E., Allard W.J., et al. Summary report of the TD-3 workshop: characterization of 83 antibodies against prostate-specific antigen. Tumor Biol 20S1 (1999) 1-12
15. Lee S.J. Expression of growth/differentiation factor 1 in the nervous system: conservation of a bicistronic structure. Proc Natl Acad Sci USA 88 (1991) 4250-4254
16. Kurlender L., Borgoño C.A., Michael I.P., Obiezu C., Elliott M.B., Yousef G.M., and Diamandis E.P. A survey of alternative transcripts of human tissue kallikrein genes [Review]. Biochim Biophys Acta 1755 (2005) 1-14
17. Kozak M. An analysis of 5′-noncoding sequences from 699 vertebrate messenger RNAs. Nucleic Acids Res 26 (1987) 8125-8148
18. Srigley J.R. Benign mimickers of prostatic adenocarcinomas. Mod Pathol 17 (2004) 328-348
19. Scorilas A., Plebani M., Mazza S., et al. Serum human glandular kallikrein (hK2) and insulin-like growth factor 1 (IGF-1) improve the discrimination between prostate cancer and benign prostatic hyperplasia in combination with total and %free PSA. Prostate 54 (2003) 220-229
20. Scorilas A., and Gregorakis A.K. mRNA expression analysis of human kallikrein 11 (KLK11) may be useful in the discrimination of benign prostatic hyperplasia form prostate cancer after needle prostate biopsy. Biol Chem 387 (2006) 789-793
21. Magklara A., Scorilas A., Catalona W.J., and Diamandis E.P. The combination of human glandular kallikrein and free prostate-specific antigen (PSA) enhances discrimination between prostate cancer and benign prostatic hyperplasia in patients with moderately increased total PSA. Clin Chem 45 (1999) 1960-1966
22. Dong Y., Kaushal A., Brattsand M., Nicklin J., and Clements J.A. Differential splicing of KLK5 and KLK7 in epithelial ovarian cancer produces novel variants with potential as cancer biomarkers. Clin Cancer Res 2 (2003) 1710-1720
23. Slawin K.M., Shariat S.F., Nguyen C., et al. Detection of metastatic prostate cancer using a splice variant-specific reverse transcriptase-polymerase chain reaction assay for human glandular kallikrein. Cancer Res 60 (2000) 7142-7148
24. Stenman U.-H. New ultrasensitive assays facilitate studies on the role of human glandular kallikrein (hK2) as a marker for prostatic disease. Clin Chem 45 (1999) 753-754
25. Graveley B.R. Alternative splicing: increasing diversity in the proteomic world [Review]. Trends Genet 17 (2001) 100-107
26. Boue S., Letunic I., and Bork P. Alternative splicing and evolution [Review]. Bioessays 25 (2003) 1031-1034
27. Xi Z., Klokk T.I., Korkmaz K., et al. Kallikrein 4 is a predominantly nuclear protein and is overexpressed in prostate cancer. Cancer Res 64 (2004) 2365-2370
28. Pampalakis G., Kurlender L., Diamandis E.P., and Sotiropoulou G. Cloning and characterization of novel isoforms of the human kallikrein 6 gene. Biochem Biophys Res Commun 320 (2004) 54-61
29. Christophi G.P., Isackson P.J., Blaber S., Blaber M., Rodriguez M., and Scarisbrick I.A. Distinct promoters regulate tissue-specific and differential expression of kallikrein 6 in CNS demyelinating disease. J Neurochem 91 (2004) 1439-1449
30. Mitsui S., Nakamura T., Okui A., Kominami K., Uemura H., and Yamaguchi N. Multiple promoters regulate tissue-specific alternative splicing of the human kallikrein gene, KLK11/hippostasin. FEBS J 273 (2006) 3678-3686